The foundation of the Transverse Myelitis (TM) market is the robust epidemiological Transverse Myelitis Market Data detailing its incidence, prevalence, and patient demographics. TM is considered a rare disease, with an estimated annual incidence rate ranging conservatively from 1 to 8 new cases per million people. However, when acquired demyelinating diseases like Multiple Sclerosis...